{"id":"https://openalex.org/W4285803226","doi":"https://doi.org/10.1182/bloodadvances.2022007530","title":"A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT","display_name":"A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT","publication_year":2022,"publication_date":"2022-07-19","ids":{"openalex":"https://openalex.org/W4285803226","doi":"https://doi.org/10.1182/bloodadvances.2022007530","pmid":"https://pubmed.ncbi.nlm.nih.gov/35851593","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9898602"},"language":"en","primary_location":{"id":"doi:10.1182/bloodadvances.2022007530","doi":"https://doi.org/10.1182/bloodadvances.2022007530","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2022007530","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/7/3/285/2033416/blooda_adv-2022-007530-main.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://ashpublications.org/bloodadvances/article-pdf/7/3/285/2033416/blooda_adv-2022-007530-main.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043346644","display_name":"Misha C. Tran","orcid":"https://orcid.org/0000-0001-8412-4470","observed_orcids":["https://orcid.org/0000-0001-8412-4470"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Misha C. Tran","raw_affiliation_strings":["1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL"],"raw_orcid":"https://orcid.org/0000-0001-8412-4470","affiliations":[{"raw_affiliation_string":"1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109801343","display_name":"Yasmin Hasan","orcid":"https://orcid.org/0009-0001-6607-5078","observed_orcids":["https://orcid.org/0009-0001-6607-5078","https://orcid.org/0009-0003-5815-7465"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yasmin Hasan","raw_affiliation_strings":["2Department of Radiation & Cellular Oncology, University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Radiation & Cellular Oncology, University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101522895","display_name":"Amy Wang","orcid":"https://orcid.org/0000-0002-1829-5877","observed_orcids":["https://orcid.org/0000-0002-1829-5877"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy Wang","raw_affiliation_strings":["1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038523162","display_name":"Kamil M. Yenice","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kamil Yenice","raw_affiliation_strings":["2Department of Radiation & Cellular Oncology, University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Radiation & Cellular Oncology, University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024933832","display_name":"J. Partouche","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julien Partouche","raw_affiliation_strings":["2Department of Radiation & Cellular Oncology, University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Radiation & Cellular Oncology, University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005939966","display_name":"Wendy Stock","orcid":"https://orcid.org/0000-0002-8349-9200","observed_orcids":["https://orcid.org/0000-0002-8349-9200"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wendy Stock","raw_affiliation_strings":["1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072420982","display_name":"Richard A. Larson","orcid":"https://orcid.org/0000-0001-9168-3203","observed_orcids":["https://orcid.org/0000-0001-9168-3203"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard A. Larson","raw_affiliation_strings":["1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL"],"raw_orcid":"https://orcid.org/0000-0001-9168-3203","affiliations":[{"raw_affiliation_string":"1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113949583","display_name":"Satyajit Kosuri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Satyajit Kosuri","raw_affiliation_strings":["1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006788504","display_name":"James L. LaBelle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James L. LaBelle","raw_affiliation_strings":["3Department of Pediatrics, Section of Hematology, University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Pediatrics, Section of Hematology, University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008824892","display_name":"Justin Paul Kline","orcid":"https://orcid.org/0000-0002-2967-6448","observed_orcids":["https://orcid.org/0000-0002-2967-6448"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin Kline","raw_affiliation_strings":["1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004821244","display_name":"Peter A. Riedell","orcid":"https://orcid.org/0000-0003-2719-0580","observed_orcids":["https://orcid.org/0000-0003-2719-0580"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter A. Riedell","raw_affiliation_strings":["1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL"],"raw_orcid":"https://orcid.org/0000-0003-2719-0580","affiliations":[{"raw_affiliation_string":"1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057523501","display_name":"Andrew S. Artz","orcid":"https://orcid.org/0000-0003-0803-9607","observed_orcids":["https://orcid.org/0000-0003-0803-9607"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew S. Artz","raw_affiliation_strings":["4Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA"],"raw_orcid":"https://orcid.org/0000-0003-0803-9607","affiliations":[{"raw_affiliation_string":"4Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054855052","display_name":"Ralph R. Weichselbaum","orcid":"https://orcid.org/0000-0002-5643-8939","observed_orcids":["https://orcid.org/0000-0002-5643-8939"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ralph Weichselbaum","raw_affiliation_strings":["2Department of Radiation & Cellular Oncology, University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Radiation & Cellular Oncology, University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089893290","display_name":"Michael Russell Bishop","orcid":"https://orcid.org/0000-0002-3979-9273","observed_orcids":["https://orcid.org/0000-0002-3979-9273"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael R. Bishop","raw_affiliation_strings":["1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109935735","display_name":"Bulent Aydogan","orcid":"https://orcid.org/0000-0002-1322-7226","observed_orcids":["https://orcid.org/0000-0002-1322-7226"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Bulent Aydogan","raw_affiliation_strings":["2Department of Radiation & Cellular Oncology, University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Radiation & Cellular Oncology, University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100444842","display_name":"Hongtao Liu","orcid":"https://orcid.org/0000-0002-3190-7807","observed_orcids":["https://orcid.org/0000-0002-3190-7807"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Hongtao Liu","raw_affiliation_strings":["1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL"],"raw_orcid":"https://orcid.org/0000-0002-3190-7807","affiliations":[{"raw_affiliation_string":"1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5100444842","https://openalex.org/A5109935735"],"corresponding_institution_ids":["https://openalex.org/I40347166"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":{"value":3000,"currency":"USD","value_usd":3000},"fwci":1.3006,"has_fulltext":true,"cited_by_count":9,"citation_normalized_percentile":{"value":0.80742864,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"7","issue":"3","first_page":"285","last_page":"292"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11359","display_name":"Effects of Radiation Exposure","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11189","display_name":"Transplantation: Methods and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fludarabine","display_name":"fludarabine","score":0.8299999833106995},{"id":"https://openalex.org/keywords/melphalan","display_name":"melphalan","score":0.9990000128746033},{"id":"https://openalex.org/keywords/second-allogeneic-stem-cell-transplantation","display_name":"second allogeneic stem cell transplantation","score":0.8600000143051147},{"id":"https://openalex.org/keywords/relapsed-hematologic-malignancies","display_name":"relapsed hematologic malignancies","score":0.9729999899864197},{"id":"https://openalex.org/keywords/conditioning-regimen","display_name":"conditioning regimen","score":0.8090000152587891},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7829999923706055},{"id":"https://openalex.org/keywords/graft-versus-host-disease","display_name":"graft-versus-host disease","score":0.9399999976158142},{"id":"https://openalex.org/keywords/treatment-related-mortality","display_name":"non-relapse mortality","score":0.9470000267028809},{"id":"https://openalex.org/keywords/engraftment","display_name":"engraftment","score":0.7960000038146973},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7020000219345093}],"concepts":[{"id":"https://openalex.org/C2778684742","wikidata":"https://www.wikidata.org/wiki/Q2298283","display_name":"Melphalan","level":3,"score":0.8741203546524048},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.8324917554855347},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7046216130256653},{"id":"https://openalex.org/C2908731994","wikidata":"https://www.wikidata.org/wiki/Q2509220","display_name":"Hematologic Neoplasms","level":3,"score":0.6185649037361145},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5218799710273743},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49058809876441956},{"id":"https://openalex.org/C2777334693","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Maximum tolerated dose","level":3,"score":0.4305151104927063},{"id":"https://openalex.org/C2909984355","wikidata":"https://www.wikidata.org/wiki/Q2509220","display_name":"Hematologic malignancy","level":2,"score":0.4101325273513794},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.339687705039978},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.31289833784103394},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.21872037649154663},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.12037467956542969}],"mesh":[{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008558","descriptor_name":"Melphalan","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014740","descriptor_name":"Vidarabine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D018380","descriptor_name":"Hematopoietic Stem Cell Transplantation","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D019337","descriptor_name":"Hematologic Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1182/bloodadvances.2022007530","doi":"https://doi.org/10.1182/bloodadvances.2022007530","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2022007530","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/7/3/285/2033416/blooda_adv-2022-007530-main.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9898602","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9898602","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Adv","raw_type":"Text"},{"id":"pmid:35851593","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35851593","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood advances","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":{"id":"doi:10.1182/bloodadvances.2022007530","doi":"https://doi.org/10.1182/bloodadvances.2022007530","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2022007530","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/7/3/285/2033416/blooda_adv-2022-007530-main.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G8940433359","display_name":null,"funder_award_id":"CA014599","funder_id":"https://openalex.org/F4320309626","funder_display_name":"University of Chicago"}],"funders":[{"id":"https://openalex.org/F4320309626","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28"},{"id":"https://openalex.org/F4320333936","display_name":"University of Chicago Medicine","ror":"https://ror.org/0076kfe04"},{"id":"https://openalex.org/F4320337886","display_name":"Comprehensive Cancer Center, University of Chicago Medical Center","ror":"https://ror.org/042wftp98"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4285803226.pdf","grobid_xml":"https://content.openalex.org/works/W4285803226.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W1491993932","https://openalex.org/W1579352764","https://openalex.org/W1961045948","https://openalex.org/W1973177688","https://openalex.org/W1979550309","https://openalex.org/W1995090169","https://openalex.org/W2036116596","https://openalex.org/W2042656357","https://openalex.org/W2043009009","https://openalex.org/W2054836967","https://openalex.org/W2064085613","https://openalex.org/W2074326274","https://openalex.org/W2078412696","https://openalex.org/W2093984971","https://openalex.org/W2096793413","https://openalex.org/W2102124437","https://openalex.org/W2108056629","https://openalex.org/W2122657363","https://openalex.org/W2128812336","https://openalex.org/W2143200412","https://openalex.org/W2147159278","https://openalex.org/W2257559310","https://openalex.org/W2284308438","https://openalex.org/W2379365975","https://openalex.org/W2915634848","https://openalex.org/W2923991522","https://openalex.org/W2983815179","https://openalex.org/W3114717619","https://openalex.org/W3132424591","https://openalex.org/W3164378773"],"related_works":["https://openalex.org/W3094802323","https://openalex.org/W4402906895","https://openalex.org/W4387208031","https://openalex.org/W2102124437","https://openalex.org/W2742094161","https://openalex.org/W1977590412","https://openalex.org/W2119471374","https://openalex.org/W3097830820","https://openalex.org/W2034519717","https://openalex.org/W2167685544"],"abstract_inverted_index":{"Relapse":[0],"after":[1],"allogeneic":[2],"stem":[3],"cell":[4],"transplantation":[5],"(allo-SCT)":[6],"remains":[7,31],"the":[8,28,46,106],"primary":[9,107],"cause":[10],"of":[11,25,45,48,83,128,151,184],"treatment":[12],"failure.":[13],"A":[14],"second":[15,74,189],"SCT":[16],"can":[17],"result":[18],"in":[19,22],"long-term":[20],"survival":[21,163,166],"a":[23,35,96],"subset":[24],"patients,":[26],"but":[27],"relapse":[29,152],"rate":[30],"high.":[32],"We":[33,171,180],"conducted":[34],"single-center,":[36],"phase":[37],"1,":[38],"modified":[39],"3":[40,42,98],"+":[41],"dose-escalation":[43],"study":[44],"feasibility":[47],"combining":[49,174],"intensity-modulated":[50],"total":[51],"marrow":[52],"irradiation":[53],"(IM-TMI)":[54],"with":[55,69,80,176,186],"fludarabine":[56],"and":[57,64,115,120,164,169],"melphalan":[58],"for":[59,188,197],"conditioning.":[60],"Between":[61],"December":[62],"2015":[63],"May":[65],"2020,":[66],"21":[67],"patients":[68],"relapsed":[70],"hematologic":[71],"disease":[72,130],"undergoing":[73],"or":[75,88,99,199],"greater":[76],"allo-SCT":[77],"were":[78,118,167],"treated":[79],"IM-TMI":[81,175,185],"doses":[82],"6":[84],"Gy,":[85,87],"9":[86,192],"12":[89,182],"Gy.":[90],"Dose-limiting":[91],"toxicity":[92],"was":[93,105,131,144,156],"defined":[94],"as":[95],"grade":[97],"higher":[100],"treatment-related":[101],"adverse":[102],"event;":[103],"mucositis":[104],"dose-limiting":[108],"toxicity.":[109],"The":[110,124,138],"median":[111],"times":[112],"to":[113],"neutrophil":[114],"platelet":[116],"engraftment":[117],"10":[119],"18":[121],"days,":[122],"respectively.":[123],"1-year":[125],"cumulative":[126],"incidence":[127,150],"graft-versus-host":[129],"65%":[132],"(95%":[133,146,158],"confidence":[134],"interval":[135],"CI,":[136,147,159],"38-83).":[137],"nonrelapse":[139],"mortality":[140],"at":[141,153],"2":[142,154],"years":[143,155],"17%":[145],"4-39).":[148],"Cumulative":[149],"35%":[157],"13-58).":[160],"Two-year":[161],"progression-free":[162],"overall":[165],"48%":[168],"50%.":[170],"conclude":[172],"that":[173],"fludarabine-melphalan":[177,187],"is":[178],"feasible.":[179],"recommend":[181],"Gy":[183,193],"SCT,":[190],"although":[191],"may":[194],"be":[195],"used":[196],"older":[198],"underweight":[200],"patients.":[201]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-07-19T00:00:00"}